Literature DB >> 30755117

Double-trabecular metal cup technique for the management of Paprosky type III defects without pelvic discontinuity.

Mattia Loppini1,2, Paolo Schiavi3, Antonello Della Rocca2, Francesco Traverso2, Federico Della Rocca2, Giuseppe Mazziotta2, Franco Astore2, Guido Grappiolo2.   

Abstract

INTRODUCTION: : Modular reconstruction systems based on trabecular metal (TM) prosthetic components have been increasingly used in the last decade for the management of severe acetabular bone defects. The aim of this study was to assess the clinical and radiographic outcomes of double-cup technique for the management of Paprosky type III defects without pelvic discontinuity.
METHODS: : A retrospective review was performed for all patients undergoing acetabular reconstruction with 2 TM cups at a tertiary referral centre between 2010 and 2015. Harris Hip Scores (HHS) and Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC) scores were evaluated preoperatively and at the latest follow-up. Radiographic assessment of the hip centre of rotation (COR) position and leg length discrepancy (LLD) was performed preoperatively and postoperatively. Osteolysis and radiolucencies, loosening of the implants, and heterotopic ossifications were evaluated with the latest follow-up radiographs.
RESULTS: : Patients included 5 men and 11 women (16 hips) with an average age of 68 (45-81) years. Acetabular bone defects included 9 Paprosky type IIIB and 7 type IIIA defects. No pelvic discontinuities were registered. The mean follow-up was 34 (24-72) months. HHS and WOMAC scores, LLD and COR position significantly improved after surgery. In only 1 (6.3%) hip a not progressive radiolucent line adjacent the acetabular construct was noted. Heterotopic ossifications were found in 2 (12.5%) hips. No patients underwent acetabular components revision surgery for any reason.
CONCLUSION: : The double-cup technique could be considered an effective management of selected Paprosky type III defects without pelvic discontinuity providing excellent clinical and radiographic outcomes in the short term.

Entities:  

Keywords:  Acetabular defect; hip arthroplasty; revision; trabecular metal

Mesh:

Substances:

Year:  2018        PMID: 30755117     DOI: 10.1177/1120700018813208

Source DB:  PubMed          Journal:  Hip Int        ISSN: 1120-7000            Impact factor:   2.135


  6 in total

1.  Survival and outcome of total elbow arthroplasty for distal humeral fracture at long term follow-up.

Authors:  Paolo Schiavi; Francesco Pogliacomi; Alice Garzia; Piergiulio Valenti; Francesco Ceccarelii; Filippo Calderazzi
Journal:  Acta Biomed       Date:  2020-12-30

2.  Efficacy and safety of viscosupplementation with hyaluronic acid for hip osteoarthritis: results from a cross-sectional study with a minimum follow-up of 4 years.

Authors:  Paolo Schiavi; Filippo Calderazzi; Martina Francesca Pedrini; Fabrizio Tacci; Enrico Vaienti; Francesco Pogliacomi
Journal:  Acta Biomed       Date:  2020-12-30

3.  Multicup reconstruction technique for the management of severe protrusio acetabular defects.

Authors:  Baochao Ji; Guoqing Li; Xiaogang Zhang; Yang Wang; Wenbo Mu; Li Cao
Journal:  Arthroplasty       Date:  2021-07-06

Review 4.  Dair approach in 7 infected total hip arthroplasties: our experience and current concepts of the literature.

Authors:  Paolo Schiavi; Francesco Pogliacomi; Filippo Calderazzi; Marco Domenichini; Francesco Ceccarelli; Enrico Vaienti
Journal:  Acta Biomed       Date:  2022-03-10

Review 5.  Clinical and radiological outcomes of jumbo cup in revision total hip arthroplasty: A systematic review.

Authors:  Qiuyuan Wang; Qi Wang; Pei Liu; Juncheng Ge; Qidong Zhang; Wanshou Guo; Weiguo Wang
Journal:  Front Surg       Date:  2022-10-04

6.  Mid-term results of revision surgery using double-trabecular metal cups alone or combined with impaction bone grafting for complex acetabular defects.

Authors:  Xianghong Zhang; Zhihong Li; Wanchun Wang; Tang Liu; Weiqiu Peng
Journal:  J Orthop Surg Res       Date:  2020-08-06       Impact factor: 2.359

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.